We discuss how the legacy of racism in American healthcare continues to affect today’s research, and share strategies for programs to communicate with underrepresented and marginalized populations.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
From unethical experimentation to systematic exclusion, racism has played a terrible role in the development of American healthcare. On this mini-podcast, we discuss how the legacy of clinical trials continues to affect today’s research, and share strategies for cancer programs to effectively communicate with underrepresented and marginalized populations.
Guest: Christopher Lathan, MD, MS, MPH, Medical Director, Dana-Farber Cancer Institute at St. Elizabeth's Medical Center; Associate Medical Director, DFCI Network
Related Content:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
